Journal of Health Sciences & Research

Register      Login

VOLUME 11 , ISSUE 2 ( July-Dec, 2020 ) > List of Articles


Comparative Assessment of Gingival Overgrowth: A Clinicopathologic Study

Shruti Srinivasan,, NS Priya, Kavita Rao, HS Umadevi, T Smitha, HS Sheethal

Citation Information : Srinivasan, S, Priya N, Rao K, Umadevi H, Smitha T, Sheethal H. Comparative Assessment of Gingival Overgrowth: A Clinicopathologic Study. J Health Sci Res 2020; 11 (2):37-41.

DOI: 10.5005/jp-journals-10042-1093

License: CC BY-NC 4.0

Published Online: 06-04-2021

Copyright Statement:  Copyright © 2020; The Author(s).


Introduction: Gingival overgrowth (GO) is the increase in the size of the gingiva due to various causes. The knowledge about their diverse clinical and histopathological features helps us in their diagnosis, treatment, and management. Aim and objective: To understand the clinical and the histopathological spectrum of inflammatory gingival overgrowth (IGO), drug-induced gingival overgrowth (DIGO), and hereditary gingival overgrowth (HGO). Settings and design: Ninety histopathologically diagnosed cases of IGO, DIGO, and HGO were studied. Materials and methods: 5 micron sections were stained with H & E. The clinical and the histopathological variables of epithelium and connective tissue were compared. Statistical analysis used: Chi-squared test was done to compare the variables among the groups. Results: The parameters, namely, age, site, color, consistency, shape, epithelium, rete ridges, inflammation, inflammatory cell predominance, vascularity, fibrosis, and hyalinization showed significant variation between the study groups. Conclusions: In this study, IGO, DIGO, and HGO showed a female predominance and most cases of IGO and HGO occurred in the 3rd–4th decade whereas DIGO in the 5th–6th decade. Clinically, IGO appeared erythematous and soft in consistency compared to DIGO and HGO, which appeared pink clinically and firm in consistency and all the three study groups showed a site predilection of the maxillary anterior region. Histopathologically IGO showed more inflammatory components than DIGO and HGO which showed more fibrotic connective tissues than IGO.

  1. Banita M, Pisoschi C, Fusaru AM, et al. Myofibroblast involvement in collagen synthesis in gingival overgrowth. Ann Romanian Soc Cell Biol 2009;15(1):129–135.
  2. Takei N, Carranza K. Carranza's Clinical Periodontology, 10th edition. Saunders; 2006.
  3. Verma PK, Srivastava R, Baranwal HC, et al. “Pyogenic granuloma—hyperplastic lesion of the gingiva: case reports”. Open Dent J 2012;6:153–156. DOI: 10.2174/1874210601206010153.
  4. Prasanna J, Sehrawat S. Fibroepithelial hyperplasia: rare, selflimiting condition—two case reports. J Adv Oral Res October 2011;2(3):63–70. DOI: 10.1177/2229411220110324.
  5. Damasceno LS, Gonçalves LS, Silva EC, et al. Stromal myofibroblasts in focal reactive overgrowths of the gingiva. Braz Oral Res 2012;26(4):373–377. DOI: 10.1590/s1806-83242012005000012.
  6. Sumarta NPM, Kamadjaja DB. Fibrous epulis associated with impacted lower right third molar. Dent J (Maj Ked Gigi) 2009;42(4):172–174. DOI: 10.20473/j.djmkg.v42.i4.p172-174.
  7. Al-Rawi NH. Localized reactive lesions of gingiva: a clinicopathological study of 638 lesions from Iraq. Internet J Dent Sci 2009;7:1.
  8. Ramu S, Rodrigues C. Reactive hyperplastic lesions of gingiva: a retrospective study of 260 cases. World J Dent 2012;3(2):126–130. DOI: 10.5005/jp-journals-10015-1142.
  9. Dongari-Bagtzoglou A. Drug-associated gingival enlargement. J Periodontol 2004;75(10):1424–1431. DOI: 10.1902/jop.2004.75.10.1424.
  10. Kumar A, Kumar V, Singh JD. Drug induced gingival hyperplasia: an updated review. Int J Pharmacol Toxicol Sci 2011;1:34–42.
  11. Marshall RI, Bartold PM. A clinical review of drug-induced gingival overgrowths. Aust Dent J 1999;44(4):219–232. DOI: 10.1111/j.1834-7819.1999.tb00224.x.
  12. Kantarci A, Nseir Z, Kim YS, et al. Loss of basement membrane integrity in human gingival overgrowth. J Dent Res 2011;90(7):887–893. DOI: 10.1177/0022034511404703.
  13. Lin K, Guilhoto LMFF, Yacubian EMT. Drug induced gingival enlargement—Part II. Antiepileptic drugs: not only phenytoin is involved. J Epilepsy Clin Neurophysiol 2007;13(2):83–88. DOI: 10.1590/S1676-26492007000200009.
  14. Sume SS, Kantarci A, Lee A, et al. Epithelial to mesenchymal transition in gingival overgrowth. Am J Pathol 2010;177(1):208–218. DOI: 10.2353/ajpath.2010.090952.
  15. Häkkinen L, Csiszar A. Hereditary gingival fibromatosis: characteristics and novel putative pathogenic mechanisms. J Dent Res 2007;86(1):25–34. DOI: 10.1177/154405910708600104.
  16. Koyuncu BÖ, Çetingül E, Kandemir Ş, et al. Hereditary gingival fibromatosis: a case report. clinical Dentistry And Research 2012;36:54–58.
  17. Nayak PA, Nayak UA, Khandelwal V, et al. Idiopathic gingival fibromatosis. Int J Clin Pediatr Dent 2011;4(1):77–81. DOI: 10.5005/jp-journals-10005-1086.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.